Advertisement
Screener

Medpace Holdings, Inc. (MEDP) Current Ratio

Medpace Holdings, Inc. (MEDP) Current Ratio

  • Current ratio · latest quarter: Value 0.73×; Formula and calculation Current assets / current liabilities..

Current ratio

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Current ratio · latest quarter0.73×Current assets / current liabilities.

$1.05B ÷ $1.44B ≈ 0.73×

Calculation inputs

InputAmount with unitRaw financial data
Current assets1.05B USDAssets, Current
Current obligations1.44B USDLiabilities, Current
Cash and equivalents502.69M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Customer receivables(m)
Inventory(m)
Payables37.53M USDAccounts Payable, Current
Borrowing debt due within one year(m)Long-term Debt, Current Maturities

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCurrent assets (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory (USD)Payables (USD)Borrowing debt due within one year (USD)Current ratio
2026-06-30$1.05B$1.44B$502.69M(m)(m)(m)$37.53M(m)0.73×
2026-03-31$1.14B$1.35B$652.68M(m)(m)(m)$34.43M(m)0.85×
2025-12-31$989.62M$1.34B$497.05M(m)(m)(m)$28.14M(m)0.74×
2025-09-30$737.28M$1.28B$285.35M(m)(m)(m)$26.52M(m)0.57×
2025-06-30$520.80M$1.22B$46.33M(m)(m)(m)$43.27M(m)0.43×
2025-03-31$821.44M$1.12B$441.44M(m)(m)(m)$61.32M(m)0.73×
2024-12-31$1.03B$1.10B$669.44M(m)(m)(m)$32.53M(m)0.93×
2024-09-30$1.03B$1.04B$656.90M(m)(m)(m)$26.20M(m)0.99×
2024-06-30$872.52M$993.09M$510.89M(m)(m)(m)$27.39M(m)0.88×
2024-03-31$744.90M$956.64M$407.01M(m)(m)(m)$24.40M(m)0.78×
2023-12-31$593.83M$925.13M$245.45M(m)(m)(m)$31.87M(m)0.64×
2023-09-30$448.88M$848.52M$95.21M(m)(m)(m)$29.02M(m)0.53×
2023-06-30$378.93M$852.44M$39.14M(m)(m)(m)$33.61M(m)0.44×
2023-03-31$367.62M$881.89M$46.92M(m)(m)(m)$37.11M(m)0.42×
2022-12-31$333.96M$803.47M$28.27M(m)(m)(m)$33.07M(m)0.42×
2022-09-30$337.74M$820.87M$31.01M(m)(m)(m)$28.25M(m)0.41×
2022-06-30$328.89M$878.96M$42.55M(m)(m)(m)$28.80M(m)0.37×
2022-03-31$355.97M$579.43M$82.84M(m)(m)(m)$25.43M(m)0.61×
2021-12-31$690.91M$557.22M$461.30M(m)(m)(m)$25.68M(m)1.24×
2021-09-30$641.22M$517.18M$398.39M(m)(m)(m)$25.05M(m)1.24×
2021-06-30$550.10M$472.61M$339.01M(m)(m)(m)$23.33M(m)1.16×
2021-03-31$533.38M$447.31M$332.88M(m)(m)(m)$21.35M(m)1.19×
2020-12-31$473.65M$440.11M$277.77M(m)(m)(m)$26.55M(m)1.08×
2020-09-30$395.00M$358.40M$219.23M(m)(m)(m)$15.88M(m)1.10×
2020-06-30$319.08M$337.98M$160.90M(m)(m)(m)$14.88M(m)0.94×
2020-03-31$303.00M$338.65M$134.00M(m)(m)(m)$16.98M(m)0.89×
2019-12-31$317.03M$343.00M$131.92M(m)(m)(m)$22.40M(m)0.92×
2019-09-30$250.40M$314.39M$79.29M(m)(m)(m)$20.68M(m)0.80×
2019-06-30$194.34M$296.07M$20.10M(m)(m)(m)$22.69M(m)0.66×
2019-03-31$182.38M$264.54M$30.13M(m)(m)(m)$13.63M(m)0.69×
2019-01-01$177.74M$263.12M(m)(m)(m)(m)(m)(m)0.68×
2018-12-31$178.11M$257.03M$23.27M(m)(m)(m)$16.74M(m)0.69×
2018-09-30$153.09M$232.13M$22.24M(m)(m)(m)$13.60M$0.000.66×
2018-06-30$158.48M$233.16M$22.23M(m)(m)(m)$16.86M$16.50M0.68×
2018-03-31$153.75M$232.49M$22.25M(m)(m)(m)$17.92M$16.50M0.66×
2017-12-31$129.97M$192.71M$26.48M(m)(m)(m)$16.67M$16.50M0.67×
2017-09-30$117.03M$172.36M$24.17M(m)(m)(m)$9.97M$15.47M0.68×
2017-06-30$123.12M$155.26M$29.05M(m)(m)(m)$7.20M$14.44M0.79×
2017-03-31$128.32M$150.04M$29.32M(m)(m)(m)$8.35M$13.41M0.86×
2016-12-31$133.25M$168.60M$37.10M(m)(m)(m)$10.91M$12.38M0.79×
2016-09-30$120.53M$156.59M$14.64M(m)(m)(m)$9.34M$6.00K0.77×
2015-12-31$94.72M$134.02M$14.88M(m)(m)(m)$8.73M$59.00K0.71×

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71